01 5Nesina
02 1Nesina/Vipidia-F *2
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 525
2018 Revenue in Millions : 512
Growth (%) : 2
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 555
2019 Revenue in Millions : 535
Growth (%) : 4
Main Therapeutic Indication : Endocrinology
Currency : USD
2021 Revenue in Millions : 111
2020 Revenue in Millions : 532
Growth (%) : -78
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 438
2015 Revenue in Millions : 438
Growth (%) : 0
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 501
2016 Revenue in Millions : 468
Growth (%) : 7
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 496
2017 Revenue in Millions : 470
Growth (%) : 6%
LOOKING FOR A SUPPLIER?